EUVIMEDEUVIMED entdecken
Open Access

Exploring biological activities of novel Schiff bases derived from amlodipine and in silico molecular modeling studies

Anum Masood iD, Mohsin Abbas Khan, Mashooq A Bhat, Breena Awan iD, Ramsha Hanif, Asim Raza iD, Saharish Khaliq, Javaid Ahmed, Farhat Ullah

Future Medicinal Chemistry · 16.11.2024 · 16 (22) · 2383-2394

DOI: 10.1080/17568919.2024.2401313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 20.09.2024. Verfasst von Anum Masood und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The islamia University of Bahawalpur, P.O Box 63100, Pakistan. Hauptthemen laut MEDLINE: Schiff Bases, Amlodipine, Anti-Bacterial Agents, Antihypertensive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim: Calcium channel antagonists are of considerable interest in treating elevated blood pressure and its pathologies.Materials & methods: Schiff base derivatives of amlodipine were produced to check its urease inhibition potentials as well antibacterial and antioxidant activities. Structural illustration along with chemical characterization were achieved by spectral techniques (1H NMR, FTIR, 13C NMR) and docking studies also performed.Results & conclusion: 3g displayed remarkable anti-hypertensive activity compared with parent drug. 3b, 3f and 3g showed urease inhibition potentials. These compounds can aid as lead for further investigations since they exhibited comparable or superior interactions. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schiff BasesAmlodipineAnti-Bacterial AgentsAntihypertensive AgentsMolecular Docking SimulationUreaseAntioxidantsCalcium Channel BlockersEnzyme InhibitorsMicrobial Sensitivity TestsHumansModels, MolecularMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

DPPHNMRSchiff baseanti-hypertensiveurease enzyme inhibition

Substanzen

Schiff BasesAmlodipineAnti-Bacterial AgentsAntihypertensive AgentsUreaseAntioxidantsCalcium Channel BlockersEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The islamia University of Bahawalpur, P.O Box 63100, Pakistan.
  • Institute of Pharmaceutical Science, Faculty of Life Science and Medicine, King's College, London, SE1 9NH, UK.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University Riyadh, P.O Box 11451, Saudi Arabia.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, University of Punjab, Lahore, P.O Box 05422, Pakistan.

ORCID-Profile: Anum Masood, Breena Awan, Asim Raza

Zitieren

APA

Masood, A., Khan, M. A., Bhat, M. A., Awan, B., Hanif, R., Raza, A., Khaliq, S., Ahmed, J., & Ullah, F. (2024). Exploring biological activities of novel Schiff bases derived from amlodipine and in silico molecular modeling studies. Future Medicinal Chemistry, 16(22), 2383-2394. https://doi.org/10.1080/17568919.2024.2401313

Vancouver

Masood A, Khan MA, Bhat MA, Awan B, Hanif R, Raza A, et al. Exploring biological activities of novel Schiff bases derived from amlodipine and in silico molecular modeling studies. Future Medicinal Chemistry. 2024;16(22):2383-2394. doi:10.1080/17568919.2024.2401313

BibTeX
@article{Masood2024,
  author = {Masood, Anum and Khan, Mohsin Abbas and Bhat, Mashooq A and Awan, Breena and Hanif, Ramsha and Raza, Asim and Khaliq, Saharish and Ahmed, Javaid and Ullah, Farhat},
  title = {Exploring biological activities of novel Schiff bases derived from amlodipine and in silico molecular modeling studies},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  volume = {16},
  number = {22},
  pages = {2383--2394},
  doi = {10.1080/17568919.2024.2401313}
}
Kostenlos starten →